ANGN · Categories · Form 4
ANGN - SEC Form 4 insider transactions
Angion Biomedica Corp. (ANGN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ANGN
- SEC Form 4 filed by Demuth Peter4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Haqq Christopher4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Piekos Brian4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Connelly Robert4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Wilson Karen J4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Chudnovsky Yekaterina4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Nissenson Allen4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Adams Julian4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Venkatesan Jay4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Ashe Carol Gail4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Ruffolo Robert R4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4 filed by Piekos Brian4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 4: Goldberg Itzhak covered exercise/tax liability with 32,082 shares, decreasing direct ownership by 2% to 1,687,986 units to cover taxes4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4 filed by Ganzi Victor F4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4 filed by Nissenson Allen4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4 filed by Wilson Karen J4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4 filed by Omenn Gilbert S4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Venkatesan Jay exercised 396,329 in-the-money shares at a strike of $6.43, sold $2,546,832 worth of shares (159,177 units at $16.00) and converted options into 262 shares, increasing direct ownership by 20% to 1,439,525 units (Amendment)4/A - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Ganzi Victor F exercised 614,310 in-the-money shares at a strike of $6.43 and sold $3,947,520 worth of shares (246,720 units at $16.00), increasing direct ownership by 81% to 823,117 units (Amendment)4/A - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Venkatesan Jay bought $14,103 worth of shares (11,313 units at $1.25), increasing direct ownership by 0.60% to 1,891,947 units4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Venkatesan Jay bought $101,428 worth of shares (82,200 units at $1.23), increasing direct ownership by 5% to 1,721,457 units4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Nissenson Allen bought $10,925 worth of shares (9,383 units at $1.16)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4 filed by Venkatesan Jay4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4 filed by Neylan John F.4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4 filed by Rhodes Jennifer J4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4 filed by Curhan Gregory S4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Venkatesan Jay bought $730,373 worth of shares (277,244 units at $2.63), increasing direct ownership by 20% to 1,639,257 units4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Venkatesan Jay bought $8,976 worth of shares (3,527 units at $2.54), increasing direct ownership by 0.26% to 1,362,013 units4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Neylan John F. sold $938 worth of shares (358 units at $2.62) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 35,136 units (withholding obligation)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Venkatesan Jay bought $105,951 worth of shares (41,625 units at $2.55), increasing direct ownership by 3% to 1,358,486 units4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Venkatesan Jay covered exercise/tax liability with 41,091 shares and bought $186,956 worth of shares (77,604 units at $2.41), increasing direct ownership by 3% to 1,316,861 units (tax liability)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Curhan Gregory S bought $9,480 worth of shares (4,000 units at $2.37)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Rhodes Jennifer J sold $1,090 worth of shares (451 units at $2.42) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 30,399 units to satisfy tax liability4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Goldberg Itzhak sold $107,721 worth of shares (32,118 units at $3.35) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,720,068 units4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Goldberg Itzhak sold $410,211 worth of shares (117,882 units at $3.48) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 1,752,186 units4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Neylan John F. sold $1,545 worth of shares (374 units at $4.13) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 35,494 units (tax liability)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Goldberg Itzhak covered exercise/tax liability with 47,410 shares and sold $629,051 worth of shares (150,000 units at $4.19) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 1,870,068 units (tax withholding)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Rhodes Jennifer J sold $1,905 worth of shares (433 units at $4.40) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 30,850 units (withholding tax)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Neylan John F. sold $3,215 worth of shares (373 units at $8.62) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 35,868 units (tax withholding)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Rhodes Jennifer J sold $3,720 worth of shares (430 units at $8.65) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 31,283 units (tax liability)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Neylan John F. sold $3,786 worth of Common Stock (376 units at $10.07), decreasing direct ownership by 1% to 36,241 units to satisfy tax liability4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Rhodes Jennifer J sold $4,575 worth of Common Stock (430 units at $10.64), decreasing direct ownership by 1% to 31,713 units (tax liability)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Eisa-Abc Llc decreased direct ownership by 25% to 2,740,978 units4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Neylan John F. sold $3,440 worth of Common Stock (381 units at $9.03), decreasing direct ownership by 1% to 36,617 units to cover withholding tax4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Rhodes Jennifer J sold $4,753 worth of Common Stock (445 units at $10.68), decreasing direct ownership by 1% to 32,143 units (for tax liability)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Rhodes Jennifer J sold $4,726 worth of Common Stock (432 units at $10.94), decreasing direct ownership by 1% to 32,588 units to satisfy tax liability4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Neylan John F. sold $4,008 worth of Common Stock (365 units at $10.98), decreasing direct ownership by 0.98% to 36,998 units to cover withholding tax4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4 filed by Angion Biomedica Corp.4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Rhodes Jennifer J sold $5,666 worth of Common Stock (427 units at $13.27), decreasing direct ownership by 1% to 33,020 units to satisfy withholding tax4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Rhodes Jennifer J sold $6,125 worth of Common Stock (440 units at $13.92), decreasing direct ownership by 1% to 33,447 units (tax withholding)4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Neylan John F. sold $5,163 worth of Common Stock (381 units at $13.55), decreasing direct ownership by 0.99% to 38,092 units to cover withholding tax4 - Angion Biomedica Corp. (0001601485) (Issuer)
- SEC Form 4: Rhodes Jennifer J sold $5,989 worth of Common Stock (399 units at $15.01), decreasing direct ownership by 1% to 33,887 units (withholding obligation)4 - Angion Biomedica Corp. (0001601485) (Issuer)